% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Kilimann:163452,
author = {Kilimann, Ingo and Wucherer, Diana and Ittermann, Till and
Völzke, Henry and Bülow, Robin and Hoffmann, Wolfgang and
Grabe, Hans Jörgen and Wittfeld, Katharina and Teipel,
Stefan Johannes},
title = {{I}nverse association between the anticholinergic burden
and hippocampus volume in a population-based cohort across
the entire adult age range.},
journal = {GeroScience},
volume = {44},
number = {3},
issn = {2509-2723},
address = {[Cham]},
publisher = {Springer International Publishing},
reportid = {DZNE-2022-00212},
pages = {1715-1726},
year = {2022},
note = {(CC BY)},
abstract = {Many medications of different indications have a relevant
anticholinergic activity. The anticholinergic burden of
medication has been shown to have significant effects on the
cognition and the risk for cognitive impairment and dementia
particularly in older patients. So far, most of the studies
used data from geriatric patients and the effect of the
anticholinergic burden on brain structures is still
unexplored. Our study aimed to analyze possible associations
of hippocampus and cholinergic basal forebrain volumes as
vulnerable brain structures for the development of dementia
and the anticholinergic burden in a population-based cohort
of non-demented participants spanning the adult age range
from 21 to 80 years. We analyzed associations between
medication-related anticholinergic burden and structural MRI
volumes from participants (n = 3087, $52.2\%$ female) of the
population-based 'Study of Health in Pomerania' (SHIP).
Anticholinergic burden was obtained from the current
medication plan using the Anticholinergic Burden Scale
(ACB). All analyses were adjusted for age, sex, education,
and total intracranial volume. We found statistically
significant associations between the ACB and the left and
right hippocampus volume but not for the basal forebrain
cholinergic system. Complementary voxel-based analysis
across all participants revealed FWE-corrected (p = < 0.05)
clusters in the temporo-parietal regions reaching into
frontal areas, showing reduced volumes with higher ACB
scores. We identified an association between anticholinergic
burden of medication on hippocampal volume suggesting a
potential inverse effect of such medication. This
association highlights the importance of a careful
prescription of medication with anticholinergic activity at
any adult age.},
keywords = {Aged / Aged, 80 and over / Cholinergic Agents: therapeutic
use / Cholinergic Antagonists: adverse effects / Cognitive
Dysfunction: chemically induced / Cognitive Dysfunction:
diagnostic imaging / Cognitive Dysfunction: drug therapy /
Dementia / Female / Hippocampus: diagnostic imaging / Humans
/ Male / Alzheimer’s disease (Other) / Cognitive
impairment (Other) / Hippocampus (Other) / Medication
(Other)},
cin = {AG Teipel / AG Thyrian / AG Grabe / AG Hoffmann},
ddc = {610},
cid = {I:(DE-2719)1510100 / I:(DE-2719)1510800 /
I:(DE-2719)5000001 / I:(DE-2719)1510600},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pmc = {pmc:PMC9213601},
pubmed = {pmid:34940948},
doi = {10.1007/s11357-021-00497-w},
url = {https://pub.dzne.de/record/163452},
}